Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-22T22:31:13.621Z Has data issue: false hasContentIssue false
  • English
  • Français

Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in Puerto Rico Associated with a Novel Carbapenemase Variant

Published online by Cambridge University Press:  02 January 2015

Christopher J. Gregory ,
Eloisa Llata ,
Nicholas Stine ,
Carolyn Gould ,
Luis Manuel Santiago ,
Guillermo J. Vazquez ,
Iraida E. Robledo ,
Arjun Srinivasan ,
Richard V. Goering  and
Kay M. Tomashek
Christopher J. Gregory*
Affiliation:
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia Centers for Disease Control and Prevention Dengue Branch, San Juan, Puerto Rico
Eloisa Llata
Affiliation:
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia Division of Health Care Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Nicholas Stine
Affiliation:
University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
Carolyn Gould
Affiliation:
Division of Health Care Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Luis Manuel Santiago
Affiliation:
Centers for Disease Control and Prevention Dengue Branch, San Juan, Puerto Rico
Guillermo J. Vazquez
Affiliation:
University of Puerto Rico, School of Medicine, San Juan, Puerto Rico
Iraida E. Robledo
Affiliation:
University of Puerto Rico, School of Medicine, San Juan, Puerto Rico
Arjun Srinivasan
Affiliation:
Division of Health Care Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Richard V. Goering
Affiliation:
Creighton University School of Medicine, Omaha, Nebraska
Kay M. Tomashek
Affiliation:
Centers for Disease Control and Prevention Dengue Branch, San Juan, Puerto Rico
*
Centers for Disease Control and Prevention Dengue Branch, 1324 Calle Cañada, San Juan, PR 00920, ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Background.

Carbapenem-resistant Klebsiella pneumoniae (CRKP) is resistant to almost all antimicrobial agents, and CRKP infections are associated with substantial morbidity and mortality.

Objective.

To describe an outbreak of CRKP in Puerto Rico, determine risk factors for CRKP acquisition, and detail the successful measures taken to control the outbreak.

Design.

Two case-control studies.

Setting.

A 328-bed tertiary care teaching hospital.

Patients.

Twenty-six CRKP case patients identified during the outbreak period of February through September 2008, 26 randomly selected uninfected control patients, and 26 randomly selected control patients with carbapenem-susceptible K. pneumoniae (CSKP) hospitalized during the same period.

Methods.

We performed active case finding, including retrospective review of the hospital's microbiology database and prospective perirectal surveillance culture sampling in high-risk units. Case patients were compared with each control group while controlling for time at risk. We sequenced the blaKPC gene with polymerase chain reaction for 7 outbreak isolates and subtyped these isolates with pulsed-field gel electrophoresis.

Results.

In matched, multivariable analysis, the presence of wounds (hazard ratio, 19.0 [95% confidence interval {CI}, 2.5-142.0]) was associated with CRKP compared with no K. pneumoniae. Transfer between units (adjusted odds ratio [OR], 7.5 [95% CI, 1.8-31.1]), surgery (adjusted OR, 4.0 [95% CI, 1.0-15.7]), and wounds (adjusted OR, 4.9 [95% CI, 1.1-21.8]) were independent risk factors for CRKP compared to CSKP. A novel K. pneumoniae carbapenemase variant (KPC-8) was present in 5 isolates. Implementation of active surveillance for CRKP colonization and cohorting of CRKP patients rapidly controlled the outbreak.

Conclusions.

Enhanced surveillance for CRKP colonization and intensified infection control measures that include limiting the physical distribution of patients can reduce CRKP transmission during an outbreak.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 31 , Issue 5 , May 2010 , pp. 476 - 484
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Schwaber, MJ, Carmeli, Y. Carbapenem-resistant Enterobacteriaceae: a potential threat. JAMA 2008;300:2911–2913.Google ScholarPubMed
2.Schwaber, MJ, Klarfeld-Lidji, S, Navon-Venezia, S, Schwartz, D, Leavitt, A, Carmeli, Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008;52:1028–1033.CrossRefGoogle ScholarPubMed
3.Patel, G, Huprikar, S, Factor, SH, Jenkins, SG, Calfee, DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29:1099–1106.CrossRefGoogle ScholarPubMed
4.MacKenzie, FM, Forbes, KJ, Dorai-John, T, Amyes, SG, Gould, IM. Emergence of a carbapenem-resistant Klebsiella pneumoniae. Lancet 1997;350:783.CrossRefGoogle ScholarPubMed
5.Bradford, PA, Urban, C, Mariano, N, Projan, SJ, Rahal, JJ, Bush, K. Imi-penem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC (3-lactamase, and the foss of an outer membrane protein. Antimicrob Agents Chemother 1997;41:563–569.CrossRefGoogle Scholar
6.Deshpande, LM, Jones, RN, Fritsche, TR, Sader, HS. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004). Mi-crob Drug Resist 2006;12:223–230.CrossRefGoogle ScholarPubMed
7.Srinivasan, A, Patel, JB. Klebsiella pneumoniae carbapenemase-producing organisms: an ounce of prevention really is worth a pound of cure. Infect Control Hosp Epidemiol 2008;29:1107–1109.Google Scholar
8.Bratu, S, Landman, D, Haag, R, et al.Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 2005;165:1430–1435.Google Scholar
9.Bratu, S, Mooty, M, Nichani, S, et al.Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob Agents Chemother 2005;49:3018–3020.Google Scholar
10.Leavitt, A, Navon-Venezia, S, Chmelnitsky, I, Schwaber, MJ, Carmeli, Y. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother 2007;51:3026–3029.CrossRefGoogle Scholar
11.Queenan, AM, Bush, K. Carbapenemases: the versatile /3-lactamases. Clin Microbiol Rev 2007;20:440–458.CrossRefGoogle Scholar
12.Yigit, H, Queenan, AM, Anderson, GJ, et al.Novel carbapenem-hydro-lyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001;45:1151–1161.CrossRefGoogle ScholarPubMed
13.Landman, D, Bratu, S, Kochar, S, et al.Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY. J Antimicrob Chemother 2007;60:78–82.Google Scholar
14.Rice, LB, Carias, LL, Hutton, RA, Rudin, SD, Endimiani, A, Bonomo, RA. The KQ element, a complex genetic region conferring transferable resistance to carbapenems, aminoglycosides, and fluoroquinolones in Klebsiella pneumoniae. Antimicrob Agents Chemother 2008;52:3427–3429.CrossRefGoogle ScholarPubMed
15.Garner, JS, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections. In: Olmsted, RN, ed. APIC Infection Control and Applied Epidemiology: Principles and Practice. St Louis, MO: Mosby; 1996: A1–A20.Google Scholar
16.Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 19th information supplement. CLSI document. Wayne, PA: CLSI, 2009: M100–S19.Google Scholar
17.Moland, ES, Black, JA, Ourada, J, Reisbig, MD, Hanson, ND, Thomson, KS. Occurrence of newer β-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals. Antimicrob Agents Chemother 2002;46:3837–3842.CrossRefGoogle ScholarPubMed
19.Goering, RV. Pulsed-field gel electrophoresis. In: Persing, DH, Tenover, FC, Versalovic, J, et al, eds. Microbiology: Diagnostic Principles and Practice. Washington, DC: ASM Press; 2004:185–196.Google Scholar
20.Siegel, JD, Jackson, M, Chiarello, L; The Health Care Infection Control Practice Advisory Committee. 2007 Guidelines for isolation precautions: preventing transmission of infectious agents in health care settings. Centers for Disease Control and Prevention Web site, http://www.cdc.gov/hicpac/2007IP/2007isolationPrecautions.html. Accessed July 27, 2009.Google Scholar
21.Larson, EL. APIC guideline for handwashing and hand antisepsis in health care settings. Am J Infect Control 1995;23:251–269.Google Scholar
22.Ressner, RA, Murray, CK, Griffith, ME, Rasnake, MS, Hospenthal, DR, Wolf, SE. Outcomes of bacteremia in burn patients involved in combat operations overseas. J Am Coll Surg 2008;206:439–444.Google Scholar
23.Richards, MJ, Edwards, JR, Culver, DH, Gaynes, RP; National Nosocomial Infections Surveillance System. Nosocomial infections in pediatric intensive care units in the United States. Pediatrics 1999;103:e39. http://pediatrics.aappublications.org/cgi/content/full/103/4/e39. Accessed July 27, 2009.Google Scholar
24.Aly, NY, Al-Mousa, HH, Al Asar el, SM. Nosocomial infections in a medical-surgical intensive care unit. Med Princ Pract 2008;17:373–377.CrossRefGoogle Scholar
25.Kwak, YG, Choi, SH, Choo, EJ, et al.Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients. Microb Drug Resist 2005;11:165–169.CrossRefGoogle ScholarPubMed
26.Falagas, ME, Rafailidis, PI, Kofteridis, D, et al.Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother 2007;60:1124–1130.Google Scholar
27.Hidron, AI, Edwards, JR, Patel, J, et al.NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29:996–1011.CrossRefGoogle Scholar
28.Navon-Venezia, S, Leavitt, A, Schwaber, MJ, et al.First report on a hy-perepidemic clone of KAC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States. Antimicrob Agents Chemother 2009;53:818–820.Google Scholar
29.Rasheed, JK, Biddle, JW, Anderson, KF, et al.Detection of the Klebsiella pneumoniae carbapenemase type 2 carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K oxytoca carrying a common plasmid. J Clin Microbiol 2008;46:2066–2069.CrossRefGoogle Scholar
30.Wolter, DJ, Kurpiel, PM, Woodford, N, Palepou, MF, Goering, RV, Hanson, ND. Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4. Antimicrob Agents Chemother 2009;53:557–562.Google Scholar
31.Wolter, DJ, Khalaf, N, Robledo, IE, et al.Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates from Puerto Rican medical center hospitals: dissemination of KPC and IMP-18 β-lactamases. Antimicrob Agents Chemother 2009;53(4):1660–1664.CrossRefGoogle ScholarPubMed
32.Allman, RM, Goode, PS, Burst, N, Bartolucci, AA, Thomas, DR. Pressure ulcers, hospital complications, and disease severity: impact on hospital costs and length of stay. Adv Wound Care 1999;12:22–30.Google ScholarPubMed
33.Hung, EW, Darouiche, RO, Trautner, BW. Proteus bacteriuria is associated with significant morbidity in spinal cord injury. Spinal Cord 2007;45:616–620.Google Scholar
34.Hussain, R, Cevallos, ME, Darouiche, RO, Trautner, BW. Gram-negative intravascular catheter-related bacteremia in patients with spinal cord injury. Arch Phys Med Rehabil 2008;89:339–342.Google Scholar
35.Lodise, TP Jr, McKinnon, PS, Rybak, M. Prediction model to identify patients with Staphylococcus aureus bacteremia at risk for methicillin resistance. Infect Control Hosp Epidemiol 2003;24:655–661.CrossRefGoogle ScholarPubMed
36.Roghmann, MC, Siddiqui, A, Plaisance, K, Standiford, H. MRSA colonization and the risk of MRSA bacteraemia in hospitalized patients with chronic ulcers. J Hosp Infect 2001;47:98–103.CrossRefGoogle ScholarPubMed
37.Kanafani, ZA, Mehio-Sibai, A, Araj, GF, Kanaan, M, Kanj, SS. Epidemiology and risk factors for extended-spectrum β-lactamase-producing organisms: a case control study at a tertiary care center in Lebanon. Am J Infect Control 2005;33:326–332.Google Scholar
38.Lin, MF, Huang, ML, Lai, SH. Risk factors in the acquisition of extended-spectrum (3-lactamase Klebsiella pneumoniae, a case-control study in a district teaching hospital in Taiwan. J Hosp Infect 2003;53:39–45.Google Scholar
39.Eveillard, M, Quenon, JL, Rufat, P, Mangeol, A, Fauvelle, F. Association between hospital-acquired infections and patients' transfers. Infect Control Hosp Epidemiol 2001;22:693–696.Google Scholar
40. Centers for Disease Control and Prevention. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing En-terobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009;58(10):256–260.Google Scholar